An Open-label Extension Study to Evaluate Safety and Tolerability of Sotatercept [MK-7962] Administered Using a Weight-banded Approach in Participants With Pulmonary Arterial Hypertension [PAH] on Standard of Care (NCT06925750)

LIGHTRAY EXT

This trial is Currently recruiting
Registration number NCT06925750
This is an extension study, which means people who took part in MK-7962-024 (LIGHTRAY) may be able to join this study. In this extension study, people will get weight-banded doses of?sotatercept. The main goal of this study is to learn about the safety of weight-banded doses of?sotatercept?and if people tolerate it over a longer period of time.

Program & service

This trial is being run with the Heart & Lung service, and as part of the Respiratory program.

Trial phase

Phase 2

Trial participation type

This trial has been designed for the Clinical Research of a Drug.

Principal investigator

Dr Shaun Yo

Key inclusion data

Open to participants who participated in MK-7962-024 (LIGHTRAY) study only

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.